MX2013011941A - Tratamiento de infeccion por el virus de hepatitis c con alisporivir. - Google Patents

Tratamiento de infeccion por el virus de hepatitis c con alisporivir.

Info

Publication number
MX2013011941A
MX2013011941A MX2013011941A MX2013011941A MX2013011941A MX 2013011941 A MX2013011941 A MX 2013011941A MX 2013011941 A MX2013011941 A MX 2013011941A MX 2013011941 A MX2013011941 A MX 2013011941A MX 2013011941 A MX2013011941 A MX 2013011941A
Authority
MX
Mexico
Prior art keywords
hepatitis
treatment
virus infection
alisporivir
invention concerns
Prior art date
Application number
MX2013011941A
Other languages
English (en)
Inventor
Rafael Crabbé
Claudio Avila
Original Assignee
Debiopharm Int Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45937376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2013011941(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Debiopharm Int Sa filed Critical Debiopharm Int Sa
Publication of MX2013011941A publication Critical patent/MX2013011941A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere al uso de los inhibidores de ciclofilina, en el tratamiento de una infección por el virus de hepatitis C (HCV).
MX2013011941A 2011-04-13 2012-04-11 Tratamiento de infeccion por el virus de hepatitis c con alisporivir. MX2013011941A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161474946P 2011-04-13 2011-04-13
PCT/EP2012/056577 WO2012140082A1 (en) 2011-04-13 2012-04-11 Treatment of hepatitis c virus infection with alisporivir

Publications (1)

Publication Number Publication Date
MX2013011941A true MX2013011941A (es) 2014-05-28

Family

ID=45937376

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013011941A MX2013011941A (es) 2011-04-13 2012-04-11 Tratamiento de infeccion por el virus de hepatitis c con alisporivir.

Country Status (18)

Country Link
US (2) US20150104415A1 (es)
EP (1) EP2696883A1 (es)
JP (1) JP2014510772A (es)
KR (1) KR20140011379A (es)
CN (1) CN103648516A (es)
AR (1) AR085988A1 (es)
AU (2) AU2012241859A1 (es)
BR (1) BR112013025934A2 (es)
CA (1) CA2832829A1 (es)
CL (1) CL2013002914A1 (es)
IL (1) IL228725A0 (es)
MA (1) MA35029B1 (es)
MX (1) MX2013011941A (es)
RU (1) RU2013150344A (es)
SG (2) SG193908A1 (es)
TN (1) TN2013000397A1 (es)
TW (1) TW201247217A (es)
WO (1) WO2012140082A1 (es)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917888A (en) 1985-06-26 1990-04-17 Cetus Corporation Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation
US4766106A (en) 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
JP2514950B2 (ja) 1986-03-10 1996-07-10 エフ・ホフマン―ラ ロシユ アーゲー 化学修飾蛋白質，その製造法および中間体
US5595732A (en) 1991-03-25 1997-01-21 Hoffmann-La Roche Inc. Polyethylene-protein conjugates
US5382657A (en) 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
ES2174915T3 (es) 1993-11-10 2002-11-16 Enzon Inc Productos de conjugacion mejorados de un interferon con un polimero.
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
US5908621A (en) 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
WO2001081359A1 (en) 2000-04-20 2001-11-01 Schering Corporation Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
GB0320638D0 (en) 2003-09-03 2003-10-01 Novartis Ag Organic compounds
DK1793844T3 (da) * 2004-10-01 2011-03-21 Debiopharm Sa Anvendelse af [D-MeAla]3-[EtVal]4-cyklosporin til behandling af hepatitis C-infektion
AU2005322242B2 (en) 2004-12-23 2010-02-11 Novartis Ag Compositions for HCV treatment
WO2008052722A2 (en) 2006-11-02 2008-05-08 Heidelberg Pharma Ag Use of ribavirin-conjugates as an anti-viral drug

Also Published As

Publication number Publication date
EP2696883A1 (en) 2014-02-19
AU2016200061A1 (en) 2016-01-28
CA2832829A1 (en) 2012-10-18
SG10201602184TA (en) 2016-04-28
US20150104415A1 (en) 2015-04-16
RU2013150344A (ru) 2015-05-20
AU2012241859A1 (en) 2013-10-10
SG193908A1 (en) 2013-11-29
IL228725A0 (en) 2013-12-31
KR20140011379A (ko) 2014-01-28
US20160235808A1 (en) 2016-08-18
MA35029B1 (fr) 2014-04-03
TW201247217A (en) 2012-12-01
NZ615539A (en) 2016-01-29
BR112013025934A2 (pt) 2016-09-06
AR085988A1 (es) 2013-11-13
JP2014510772A (ja) 2014-05-01
WO2012140082A1 (en) 2012-10-18
CN103648516A (zh) 2014-03-19
CL2013002914A1 (es) 2014-06-27
TN2013000397A1 (en) 2015-01-20

Similar Documents

Publication Publication Date Title
CY1120374T1 (el) Ενεργοποιητες κινασων πυρουβικου για χρηση σε θεραπεια
HK1203944A1 (zh) 用於治療和預防乙型肝炎病毒感染的 -甲基-二氫嘧啶類
MX356525B (es) Vectores de virus asociados con adeno (aav) para uso en terapia de genes de coroideremia.
MX2013011479A (es) Anticuerpos anti-fgfr4 y metodos de uso.
MX2013015311A (es) Polipeptidos de enlace de pcsk9 y metodos de uso.
MD20140035A2 (ro) Metodă de tratament al hepatitei virale C
EP2736528A4 (en) COMPOSITIONS AND METHODS OF TREATING HIV
EA201490559A1 (ru) Композиция для лечения свища
PH12014501844B1 (en) Peptidomimetic macrocycles
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
MX2014004022A (es) Anticuerpos anti-htra1 y metodos de uso.
HK1210022A1 (en) Methods for the treatment of hepatitis b and hepatitis d infections
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
TW201611843A (en) Methods of treatment with arginine deiminase
RS53911B1 (en) TREATMENT IN HEPATITIS B VIRUS INFECTION ONLY OR IN COMBINATION WITH HEPATITIS DELTA VIRUS AND THE DISEASES OF THE LIVER
UY34420A (es) ?métodos de tratamiento del virus de la hepatitis c con que de gs-7977 y ribavirina, composiciones y usos"
IN2014DN00254A (es)
UA112760C2 (uk) Теобромін у комбінації з гвайфенезином для лікування кашлю
MX2013003903A (es) Nuevos tratamientos de infeccion por el virus de hepatitis c.
EA201590615A1 (ru) Стимулирующие лактацию композиции на основе фосфатидилсерина
ZA201307019B (en) Compositions for preventing and/or treating and infection by an hiv-1 virus
HK1201181A1 (en) Novel cyclosporin derivatives for the treatment and prevention of viral infections
ZA201306342B (en) The treatment of viral infections
NZ601661A (en) Compositions and methods for treating viral diseases
TN2013000397A1 (en) Treatment of hepatitis c virus infection with alisporivir